{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:51:52Z","timestamp":1793213512942,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-02031-w","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:26:02Z","timestamp":1766571962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association between vitamin D and metabolic-associated steatotic liver disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Bruno","family":"Basil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winifred","family":"Adiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ejike Lawrence","family":"Ugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngozi Ijeoma","family":"Okoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"6","key":"2031_CR1","doi-asserted-by":"publisher","first-page":"e2416381","DOI":"10.1001\/jamanetworkopen.2024.16381","volume":"7","author":"P Gin\u00e8s","year":"2024","unstructured":"Gin\u00e8s P, Serra-Burriel M, Kamath PS. Metabolic Dysfunction-Associated steatotic liver disease-The new epidemic of chronic liver disease. JAMA Netw Open. 2024;7(6):e2416381. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.16381.","journal-title":"JAMA Netw Open"},{"issue":"Suppl","key":"2031_CR2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"30","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2024;30(Suppl):S32\u201350. https:\/\/doi.org\/10.3350\/cmh.2024.0431.","journal-title":"Clin Mol Hepatol"},{"issue":"9","key":"2031_CR3","doi-asserted-by":"publisher","first-page":"bvae110","DOI":"10.1210\/jendso\/bvaf110","volume":"8","author":"F Bril","year":"2024","unstructured":"Bril F, Bolla P, Huynh K, Bobba S. Prevalence of MASLD in people with diabetes has decreased in the US, but rates of liver fibrosis are still on the rise. J Endocr Soc. 2024;8(9):bvae110. https:\/\/doi.org\/10.1210\/jendso\/bvaf110.","journal-title":"J Endocr Soc"},{"issue":"10","key":"2031_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Price JK, Owrangi S, Gundu-Rao N, Satchi R, et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2024;22(10):1999\u2013e20108. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.006.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2031_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40842-024-00187-4","volume":"10","author":"B Basil","year":"2024","unstructured":"Basil B, Myke-Mbata BK, Eze OE, Akubue AU. From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome - current insights and future directions. Clin Diabetes Endocrinol. 2024;10(1):39. https:\/\/doi.org\/10.1186\/s40842-024-00187-4.","journal-title":"Clin Diabetes Endocrinol"},{"key":"2031_CR6","doi-asserted-by":"publisher","unstructured":"Qi X, Li J, Caussy C, Teng GJ, Loomba R. Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction\u2013associated steatotic liver disease. Hepatology. 2024. 10.1097\/HEP.0000000000000913. (Epub ahead of print). https:\/\/doi.org\/10.1097\/HEP.0000000000000913","DOI":"10.1097\/HEP.0000000000000913"},{"issue":"1","key":"2031_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13098-025-01808-3","volume":"17","author":"YM Li","year":"2025","unstructured":"Li YM, Huang JY, Guo R, Li SM, Chen C, Wu M, Wang R, Liu MY, Yiu KH. Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2025;17(1):307. https:\/\/doi.org\/10.1186\/s13098-025-01808-3.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2031_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-024-02284-3","volume":"23","author":"E Han","year":"2024","unstructured":"Han E, Han KD, Lee YH, Kim KS, Hong S, Park JH, et al. Association of Temporal metabolic dysfunction-associated steatotic liver disease with type 2 diabetes, cardiovascular disease and mortality: a nationwide cohort study. Cardiovasc Diabetol. 2024;23(1):289. https:\/\/doi.org\/10.1186\/s12933-024-02284-3.","journal-title":"Cardiovasc Diabetol"},{"key":"2031_CR9","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2023","unstructured":"International Diabetes Federation. IDF diabetes atlas. 11th ed. Brussels, Belgium: International Diabetes Federation; 2023. https:\/\/www.diabetesatlas.org.","edition":"11"},{"issue":"9","key":"2031_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094901","volume":"25","author":"I Aggeletopoulou","year":"2024","unstructured":"Aggeletopoulou I, Tsounis EP, Triantos C. Vitamin D and metabolic dysfunction-associated steatotic liver disease (MASLD): novel mechanistic insights. Int J Mol Sci. 2024;25(9):4901. https:\/\/doi.org\/10.3390\/ijms25094901.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2031_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjnph-2024-000950","volume":"8","author":"DK Mangal","year":"2025","unstructured":"Mangal DK, Shaikh N, Tolani H, Gautam D, Pandey AK, Sonnathi Y, et al. Burden of micronutrient deficiency among patients with type 2 diabetes: systematic review and meta-analysis. BMJ Nutrition, Prevention & Health. 2025;8(1):e000950. https:\/\/doi.org\/10.1136\/bmjnph-2024-000950.","journal-title":"BMJ Nutrition, Prevention & Health"},{"issue":"5","key":"2031_CR12","doi-asserted-by":"publisher","first-page":"e0324729","DOI":"10.1371\/journal.pone.0324729","volume":"20","author":"S Ahi","year":"2025","unstructured":"Ahi S, Reiskarimian A, Bagherzadeh MA, Rahmanian Z, Pilban P, Sobhanian S. Impact of vitamin D on glycemic control and microvascular complications in type 2 diabetes: a cross-sectional study. PLoS One. 2025;20(5):e0324729. https:\/\/doi.org\/10.1371\/journal.pone.0324729.","journal-title":"PLoS One"},{"issue":"1","key":"2031_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365\u2013408. https:\/\/doi.org\/10.1152\/physrev.00014.2015.","journal-title":"Physiol Rev"},{"issue":"6","key":"2031_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061459","volume":"13","author":"P Jiang","year":"2025","unstructured":"Jiang P, Liu Y, Liu J, Quan J. Vitamin D attenuates hepatic sinusoidal capillarization in type 2 diabetes mellitus- metabolic dysfunction-associated fatty liver disease via dual autophagy activation and pyroptosis suppression in liver sinusoidal endothelial cells. Biomedicines. 2025;13(6):1459. https:\/\/doi.org\/10.3390\/biomedicines13061459.","journal-title":"Biomedicines"},{"issue":"3","key":"2031_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/apt.12377","volume":"38","author":"M Eliades","year":"2013","unstructured":"Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38(3):246\u201354. https:\/\/doi.org\/10.1111\/apt.12377.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"2031_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2174\/1389557518666181025153712","volume":"19","author":"L Pacifico","year":"2019","unstructured":"Pacifico L, Osborn JF, Bonci E, Pierimarchi P, Chiesa C. Association between vitamin D levels and nonalcoholic fatty liver disease: potential confounding variables. Mini Rev Med Chem. 2019;19(12):966\u201378. https:\/\/doi.org\/10.2174\/1389557518666181025153712.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"2031_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57380-9","volume":"14","author":"S Lee","year":"2024","unstructured":"Lee S, Jin MH, Yoon JH. The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction. Sci Rep. 2024;14(1):6714. https:\/\/doi.org\/10.1038\/s41598-024-57380-9.","journal-title":"Sci Rep"},{"key":"2031_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/DMSO.S348870","volume":"15","author":"Y Xing","year":"2022","unstructured":"Xing Y, Cheng T, Zhou F, Ma H. The association between vitamin D and type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease: an observational cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:111\u20139. https:\/\/doi.org\/10.2147\/DMSO.S348870.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"11","key":"2031_CR19","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.3390\/nu12113302","volume":"12","author":"I Barchetta","year":"2020","unstructured":"Barchetta I, Cimini FA, Cavallo MG. Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update. Nutrients. 2020;12(11):3302. https:\/\/doi.org\/10.3390\/nu12113302.","journal-title":"Nutrients"},{"issue":"12","key":"2031_CR20","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/ajg.2016.406","volume":"111","author":"YA Patel","year":"2016","unstructured":"Patel YA, Henao R, Moylan CA, Guy CD, Piercy DL, Diehl AM, et al. Vitamin D is not associated with severity in NAFLD: results of a paired clinical and gene expression profile analysis. Am J Gastroenterol. 2016;111(12):1774\u201381. https:\/\/doi.org\/10.1038\/ajg.2016.406.","journal-title":"Am J Gastroenterol"},{"issue":"3\u20134","key":"2031_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajg.2015.09.003","volume":"16","author":"NA Elshamy","year":"2015","unstructured":"Elshamy NA, Sedrak H, Hashem AM, Abd MS, Abdou AE, Abd IA. The association between serum levels of 25-hydroxyvitamin D and nonalcoholic fatty liver disease in the Egyptian population. Arab J Gastroenterol. 2015;16(3\u20134):80\u20136. https:\/\/doi.org\/10.1016\/j.ajg.2015.09.003.","journal-title":"Arab J Gastroenterol"},{"issue":"4","key":"2031_CR22","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.21608\/ejhm.2019.52924","volume":"77","author":"HT Kandeel","year":"2019","unstructured":"Kandeel HT, Sayed DM, Ahmed EH. The relationship between vitamin D deficiency and NAFLD in sample of Egyptian type 2 diabetic patients. Egypt J Hosp Med. 2019;77(4):5161\u20136. https:\/\/doi.org\/10.21608\/ejhm.2019.52924.","journal-title":"Egypt J Hosp Med"},{"key":"2031_CR23","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.2147\/IJGM.S319449","volume":"14","author":"L Xiu","year":"2021","unstructured":"Xiu L, Jiang T, Yao XA, Wen Z. Correlation between 25-hydroxyvitamin D levels and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus: a cross-sectional study. Int J Gen Med. 2021;14:3099\u2013107. https:\/\/doi.org\/10.2147\/IJGM.S319449.","journal-title":"Int J Gen Med"},{"issue":"1","key":"2031_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12902-021-00762-1","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li J, Ni Y, Wang Y, Liu H. Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients. BMC Endocr Disord. 2021;21(1):103. https:\/\/doi.org\/10.1186\/s12902-021-00762-1.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2031_CR25","doi-asserted-by":"publisher","DOI":"10.5812\/semj.118125","volume":"23","author":"V Sheikhi","year":"2022","unstructured":"Sheikhi V, Heidari Z. Low vitamin D level was associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Shiraz E-Med J. 2022;23(3):e118125. https:\/\/doi.org\/10.5812\/semj.118125.","journal-title":"Shiraz E-Med J"},{"issue":"6","key":"2031_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108475","volume":"37","author":"KD Corbin","year":"2023","unstructured":"Corbin KD, Pittas AG, Desouza C, Grdinovac KK, Herzig K, Kashyap SR, et al. Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study. J Diabetes Complications. 2023;37(6):108475. https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108475.","journal-title":"J Diabetes Complications"},{"issue":"2","key":"2031_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14300\/mnnc.2023.18029","volume":"18","author":"NE Khvatalin","year":"2023","unstructured":"Khvatalin NE, Svetogurova AD, Sarithala VJ, Yagoda AV, Koroy PV, Demurcheva EO. Vitamin D as a marker of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Med Vestn Sev Kavk. 2023;18(2):131\u20135. https:\/\/doi.org\/10.14300\/mnnc.2023.18029.","journal-title":"Med Vestn Sev Kavk"},{"key":"2031_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1420088","volume":"15","author":"N Huang","year":"2024","unstructured":"Huang N, Su X, Yu T, Wu X, Lu B, Sun W, et al. Serum 25-hydroxy vitamin D level is associated with elastography-detected liver fibrosis in patients with type 2 diabetes mellitus in China. Front Endocrinol (Lausanne). 2024;15:1420088. https:\/\/doi.org\/10.3389\/fendo.2024.1420088.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2031_CR29","doi-asserted-by":"publisher","first-page":"25567","DOI":"10.1038\/s41598-024-76560-1","volume":"14","author":"W Xiang","year":"2024","unstructured":"Xiang W, Cheng S, Peng Y, Jin Q, Yang J. DII modulates the relationship between SVD3 and NAFLD prevalence, rather than liver fibrosis severity, in hospitalized T2DM population. Sci Rep. 2024;14(1):25567. https:\/\/doi.org\/10.1038\/s41598-024-76560-1.","journal-title":"Sci Rep"},{"issue":"6","key":"2031_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/MCO.0000000000000605","volume":"22","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Thorne JL, Moore JB. Vitamin D and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2019;22(6):447\u201352. https:\/\/doi.org\/10.1097\/MCO.0000000000000605.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"9","key":"2031_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/nu9091015","volume":"9","author":"I Barchetta","year":"2017","unstructured":"Barchetta I, Cimini FA, Cavallo MG. Vitamin D supplementation and non-alcoholic fatty liver disease: present and future. Nutrients. 2017;9(9):1015. https:\/\/doi.org\/10.3390\/nu9091015.","journal-title":"Nutrients"},{"issue":"1","key":"2031_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12916-016-0638-y","volume":"14","author":"I Barchetta","year":"2016","unstructured":"Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, et al. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. BMC Med. 2016;14(1):92. https:\/\/doi.org\/10.1186\/s12916-016-0638-y.","journal-title":"BMC Med"},{"key":"2031_CR33","doi-asserted-by":"publisher","first-page":"732496","DOI":"10.3389\/fphar.2021.732496","volume":"12","author":"S Rezaei","year":"2021","unstructured":"Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Shabani-Borujeni M, Modaresi S, et al. The effects of vitamin D supplementation on anthropometric and biochemical indices in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Pharmacol. 2021;12:732496. https:\/\/doi.org\/10.3389\/fphar.2021.732496.","journal-title":"Front Pharmacol"},{"issue":"9","key":"2031_CR34","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1039\/d0fo01095b","volume":"11","author":"XF Guo","year":"2020","unstructured":"Guo XF, Wang C, Yang T, Li S, Li KL, Li D. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Food Funct. 2020;11(9):7525\u201336. https:\/\/doi.org\/10.1039\/d0fo01095b.","journal-title":"Food Funct"},{"issue":"4","key":"2031_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1017\/s0029665119000326","volume":"78","author":"OA Akinyemi","year":"2019","unstructured":"Akinyemi OA, Lanham-New SA, Darling AL. Vitamin D and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Proc Nutr Soc. 2019;78(4):593\u2013605. https:\/\/doi.org\/10.1017\/s0029665119000326.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"2031_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4254\/wjh.v10.i1.142","volume":"10","author":"B Saberi","year":"2018","unstructured":"Saberi B, Dadabhai AS, Nanavati J, Wang L, Shinohara RT, Mullin GE. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: a PRISMA compliant systematic review and meta-analysis of pooled data. World J Hepatol. 2018;10(1):142\u201353. https:\/\/doi.org\/10.4254\/wjh.v10.i1.142.","journal-title":"World J Hepatol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02031-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-02031-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02031-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:26:03Z","timestamp":1766571963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-025-02031-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2031"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-02031-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a systematic review and meta-analysis of previously published studies; no primary human or animal data were collected. Ethical approval was therefore not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as all data analyzed were derived from previously published studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}